ImmunityBio's total assets for Q3 2024 were $364.57M, a decrease of -17.95% from the previous quarter. IBRX total liabilities were $1.11B for the fiscal quarter, a -2.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.